ESC 365 - Improvement in liver and renal biochemistry following left ventricular assist device therapy in advanced heart failure

HFA Premium Access

Improvement in liver and renal biochemistry following left ventricular assist device therapy in advanced heart failure

Session: Poster Session 1 - Devices / CRT/ ICD / Surgery

Topic: Assist devices

Speaker: Doctor T. Musa (Guildford, GB)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Doctor Tarique Musa

Royal Surrey County Hospital, Guildford (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

34 more presentations in this session

Comparison of electrophysiological and surgical methods of treatment in patients with heart failure complicated with atrial fibrillation

Speaker: Doctor T. Troyanova-Shchutskaia (Minsk, BY)

Endocardial left ventricle lead implantation for cardiac resynchronisation therapy: an australian experience.

Speaker: Doctor C. Cheshire (Melbourne, AU)

Super-response to cardiac resynchronisation therapy

Speaker: Professor V. Kuznetsov (Tyumen, RU)

Typical left bundle branch block is associated with more favorable response to cardiac resynchronization therapy in heart failure patients

Speaker: Professor S. Kang (Seoul, KR)

Low EF as a predictor of poor CRT response

Access the full session

Poster Session 1 - Devices / CRT/ ICD / Surgery

Speakers: Doctor T. Musa, Doctor T. Troyanova-Shchutskaia, Doctor C. Cheshire, Professor V. Kuznetsov, Professor S. Kang

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources